Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-24

FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CHLOROQUINE PHOSPHATE filed by Rising Pharma Holdings, Inc. under ANDA 091621.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine phosphate (Chloroquine phosphate)

Snippet

SUPPL AP for CHLOROQUINE PHOSPHATE (CHLOROQUINE PHOSPHATE)